Skip to main content

Table 2 Comparisons of PD-L1 expression, CD4 and CD8 density between primary tumor and liver metastasis

From: PD-L1 expression in liver metastasis: its clinical significance and discordance with primary tumor in colorectal cancer

Groups

PD-L1 CPS

(median)

P value

CD4 density (%, median)

P value

CD8 density (%, median)

P value

Primary tumor

Liver metastasis

Primary tumor

Liver metastasis

Primary tumor

Liver metastasis

General

0.5

1.0

0.10

7.0

12.0

0.003*

4.5

3.5

0.63

Pre-operative che-mo/radiotherapy for primary tumor

 No

1.0

1.0

0.09

7.5

12.5

0.01*

4.0

5.0

0.78

 Yes

0.0

0.0

0.31

5.5

7.5

0.28

5.0

1.5

0.03*

Tumor differentiation

 Poor

0.0

0.0

0.63

5.5

3.0

0.68

10.0

1.5

0.07

 Moderate

0.5

1.0

0.052

7.5

15.0

0.003*

3.0

4.0

0.70

Primary tumor site

 Colon

0.0

0.0

0.27

5.3

10.0

0.03*

2.0

2.5

0.47

 Rectum

1.5

1.3

0.20

10.0

17.5

0.04*

5.0

5.0

0.95

Metastatic time model

 Concurrent

0.0

1.0

0.05*

7.5

12.5

0.01*

5.0

3.5

0.95

 Metachronous

1.5

1.0

0.22

3.0

5.0

0.22

2.0

4.0

0.32

Resection time model

 Concurrent

0.0

1.0

0.04*

8.8

15.0

0.01*

5.0

3.5

0.81

 Metachronous

1.3

0.8

0.13

5.0

5.8

0.23

3.3

3.3

0.12

  1. PD-L1 programmed death ligand 1, CPS combined positive score, CD4 cluster of differentiation 4, CD8 cluster of differentiation 8
  2. *Statistically significant